Women Remain Underrepresented in Medical Research
Women remain underrepresented in medical research, leading to gender biases that affect disease understanding and treatment. Enhanced inclusion, funding, and education are needed to address these disparities.
Published on April 2, 2025
Medical research has long been dominated by male perspectives, resulting in significant gaps that affect the understanding and treatment of diseases, particularly those that impact women. Key areas such as oncology, cardiovascular health, psychiatric disorders, and conditions unique to women like menopause and endometriosis remain underexplored due to the persistent underrepresentation of women in clinical trials.
Recent supplemental reports have added nuance to this discussion. For example, Reuters highlighted issues such as the removal of crucial public health data websites on 2025-02-04 and the controversial directive given to FDA staff concerning sensitive terms on 2025-02-20. Additionally, discussions at the TIME Women's Leadership Forum in October 2024 and subsequent reports in November 2024 suggest that leveraging technologies like AI could be instrumental in bridging these gaps and improving health equity for women.